Ozempic and Wegovy may raise hair loss risk in some men
Saturday, September 12, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
GLP-1 drugs such as Ozempic, Wegovy, and Zepbound may increase hair-loss risk by 7% in men who are already genetically susceptible to male-pattern baldness. The findings suggest thinning hair may not be caused only by rapid weight loss and could also reflect a biological link between GLP-1 activity and hair follicles. (via Science Daily)
Read the Full StoryThis article will expire in 29 days.
In the News...
View All Recent News
- Ozempic and Wegovy may raise hair loss risk in some men
- A hidden compound in healthy foods may worsen IBD
- Scientists discover a hidden switch that shuts down inflammation
- Scientists find a way to break pancreatic cancer’s protective shield
- Scientists find Ozempic may slow aging itself
- Who really needs a heart calcium scan?
- The secret to longer life may be hidden in bat DNA
- One sugary drink a day linked to more than double the risk of stomach cancer
- DNA treatment cuts bad cholesterol by nearly 50% without statins
- UCLA scientists turn cord blood into powerful cancer-fighting T cells
- Eating only 8 hours a day may help control Type 1 diabetes
- Scientists discover the human heart can regrow muscle after a heart attack
- Scientists find signs of extreme aging and youth in the same 117-year-old
- Study of 1.9 million people finds a striking link between ADHD and gut problems
- Your next prescription could be treating a side effect from the last one
- Too much light at night may quietly reshape your heart
- Caffeine may flip an ancient cellular switch linked to slower aging
- Ozempic and Wegovy linked to nearly 40% fewer asthma attacks
- Scientists find a bone-building switch that could fight osteoporosis
- Early statin use linked to 15% lower dementia risk